1
|
Lauwers M, Courties A, Sellam J, Wen C. The cholinergic system in joint health and osteoarthritis: a narrative-review. Osteoarthritis Cartilage 2021; 29:643-653. [PMID: 33609692 DOI: 10.1016/j.joca.2021.02.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/27/2020] [Revised: 01/14/2021] [Accepted: 02/02/2021] [Indexed: 02/02/2023]
Abstract
Osteoarthritis (OA) poses a major health and economic burden worldwide due to an increasing number of patients and the unavailability of disease-modifying drugs. In this review, the latest understanding of the involvement of the cholinergic system in joint homeostasis and OA will be outlined. First of all, the current evidence on the presence of the cholinergic system in the normal and OA joint will be described. Cholinergic innervation as well as the non-neuronal cholinergic system are detected. In a variety of inflammatory diseases, the classic cholinergic anti-inflammatory pathway lately received a lot of attention as via this pathway cholinergic agonists can reduce inflammation. The role of this cholinergic anti-inflammatory pathway in the context of OA will be discussed. Activation of this pathway improved the progression of the disease. Secondly, chondrocyte hypertrophy plays a pivotal role in osteophyte formation and OA development; the impact of the cholinergic system on hypertrophic chondroblasts and endochondral ossification will be evaluated. Cholinergic stimulation increased chondrocyte proliferation, delayed chondrocyte differentiation and caused early mineralisation. Moreover, acetylcholinesterase and butyrylcholinesterase affect the endochondral ossification via an acetylcholine-independent pathway. Thirdly, subchondral bone is critical for cartilage homeostasis and metabolism; the cholinergic system in subchondral bone homeostasis and disorders will be explored. An increase in osteoblast proliferation and osteoclast apoptosis is observed. Lastly, current therapeutic strategies for OA are limited to symptom relief; here the impact of smoking on disease progression and the potential of acetylcholinesterase inhibitors as candidate disease-modifying drug for OA will be discussed.
Collapse
Affiliation(s)
- M Lauwers
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong, China.
| | - A Courties
- Department of Rheumatology, Assistance Publique - Hôpitaux de Paris (AP-HP), Inserm UMRS_938, Sorbonne Université, Saint-Antoine Hospital, Paris, France.
| | - J Sellam
- Department of Rheumatology, Assistance Publique - Hôpitaux de Paris (AP-HP), Inserm UMRS_938, Sorbonne Université, Saint-Antoine Hospital, Paris, France.
| | - C Wen
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong, China.
| |
Collapse
|
2
|
den Hollander D, Croubels S, Lauwers M, Caekebeke N, Ringenier M, De Meyer F, Reisinger N, Van Immerseel F, Dewulf J, Antonissen G. Applied Research Note: Biomonitoring of mycotoxins in blood serum and feed to assess exposure of broiler chickens. J APPL POULTRY RES 2021. [DOI: 10.1016/j.japr.2020.10.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
3
|
Luo X, Lauwers M, Layer PG, Wen C. Non-neuronal Role of Acetylcholinesterase in Bone Development and Degeneration. Front Cell Dev Biol 2021; 8:620543. [PMID: 33585459 PMCID: PMC7876280 DOI: 10.3389/fcell.2020.620543] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Accepted: 12/28/2020] [Indexed: 12/14/2022] Open
Abstract
Acetylcholinesterase (AChE), an enzyme catalyzing the degradation of acetylcholine, plays an important suppressive role in the cholinergic regulation by terminating the action of acetylcholine. The expression of acetylcholinesterase and other cholinergic components is not restricted to only brain and nerve tissues but can also be found in non-neuronal tissues like the immune system and bone tissue. Primary identification of these components has been achieved. However, the information about their specific functions and underlying molecular mechanisms in bone remains scattered. Here, the physiological process of bone development, homeostasis, and degeneration are introduced. Next, the cholinergic system and its expression in bone tissue is documented. Among them, special attention goes to AChE, as the structure of this enzyme suggests diverse binding affinities, enabled by a peripheral site and a catalytic site. The peripheral site supports the non-enzymatic function of AChE in non-neuronal systems. Based on recent studies, the non-neuronal roles of acetylcholinesterase, both enzymatically and non-enzymatically, in bone development, homeostasis and degeneration are summarized briefly together with potential mechanisms to support these functions. We conclude that AChE may be a potential therapeutic target for bone diseases like osteoporosis.
Collapse
Affiliation(s)
- Xiaohe Luo
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong, China
| | - Marianne Lauwers
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong, China
| | - Paul G Layer
- Developmental Biology and Neurogenetics, Technische Universität Darmstadt, Darmstadt, Germany
| | - Chunyi Wen
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong, China
| |
Collapse
|
4
|
Lauwers M, Croubels S, De Baere S, Sevastiyanova M, Romera Sierra EM, Letor B, Gougoulias C, Devreese M. Assessment of Dried Blood Spots for Multi-Mycotoxin Biomarker Analysis in Pigs and Broiler Chickens. Toxins (Basel) 2019; 11:toxins11090541. [PMID: 31540490 PMCID: PMC6784198 DOI: 10.3390/toxins11090541] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2019] [Revised: 09/13/2019] [Accepted: 09/15/2019] [Indexed: 11/30/2022] Open
Abstract
Dried blood spots (DBSs), a micro-sampling technique whereby a drop of blood is collected on filter paper has multiple advantages over conventional blood sampling regarding the sampling itself, as well as transportation and storage. This is the first paper describing the development and validation of a method for the determination of 23 mycotoxins and phase I metabolites in DBSs from pigs and broiler chickens using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The targeted mycotoxins belong to groups for which the occurrence in feed is regulated by the European Union, namely, aflatoxins, ochratoxin A and several Fusarium mycotoxins, and to two groups of unregulated mycotoxins, namely Alternaria mycotoxins and Fusarium mycotoxins (enniatins and beauvericin). The impact of blood haematocrit, DBS sampling volume and size of the analysed DBS disk on the validation results was assessed. No effects of variation in size of the analysed disk, haematocrit and spotted blood volume were observed for most mycotoxins, except for the aflatoxins and β-zearalanol (BZAL) at the lowest haematocrit (26%) level and for the enniatins (ENNs) at the lowest volume (40 µL). The developed method was transferred to an LC-high resolution mass spectrometry instrument to determine phase II metabolites. Then, the DBS technique was applied in a proof-of-concept toxicokinetic study including a comparison with LC-MS/MS data from plasma obtained with conventional venous blood sampling. A strong correlation (r > 0.947) was observed between plasma and DBS concentrations. Finally, DBSs were also applied in a pilot exposure assessment study to test their applicability under field conditions.
Collapse
Affiliation(s)
- Marianne Lauwers
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
- Innovad Global, Postbaan 69, 2910 Essen, Belgium.
| | - Siska Croubels
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
| | - Siegrid De Baere
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
| | | | | | - Ben Letor
- Innovad Global, Postbaan 69, 2910 Essen, Belgium.
| | | | - Mathias Devreese
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
| |
Collapse
|
5
|
Lauwers M, Croubels S, Letor B, Gougoulias C, Devreese M. Biomarkers for Exposure as A Tool for Efficacy Testing of A Mycotoxin Detoxifier in Broiler Chickens and Pigs. Toxins (Basel) 2019; 11:E187. [PMID: 30925814 PMCID: PMC6520943 DOI: 10.3390/toxins11040187] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2019] [Revised: 03/22/2019] [Accepted: 03/27/2019] [Indexed: 11/20/2022] Open
Abstract
Applying post-harvest control measures such as adding mycotoxin detoxifying agents is a frequently-used mitigation strategy for mycotoxins. EFSA states that the efficacy of these detoxifiers needs to be tested using specific biomarkers for exposure. However, the proposed biomarkers for exposure are not further optimized for specific target species. Hence, the goal of this study was a) to evaluate the most suitable biomarkers for deoxynivalenol (DON) and zearalenone (ZEN) in porcine plasma, urine and feces; and DON, aflatoxin B1 (AFB1) and ochratoxin A (OTA) in plasma and excreta of broiler chickens and b) to determine the efficacy of a candidate detoxifier, as a proof-of-concept study. Therefore, a mixture of mycotoxins was administered as a single oral bolus with or without detoxifying agent. In accordance with literature AFB1, OTA, and DON-sulphate (DON-S) proved optimal biomarkers in broilers plasma and excreta whereas, in pigs DON-glucuronide (DON-GlcA) and ZEN-glucuronide (ZEN-GlcA) proved the optimal biomarkers in plasma, DON and ZEN-GlcA in urine and, ZEN in feces. A statistically significant reduction was seen between control and treatment group for both AFB1 and DON in broiler plasma, under administration of the mycotoxin blend and detoxifier dose studied suggesting thus, beneficial bioactivity.
Collapse
Affiliation(s)
- Marianne Lauwers
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
- Innovad, Postbaan 69, 2910 Essen, Belgium.
| | - Siska Croubels
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
| | - Ben Letor
- Innovad, Postbaan 69, 2910 Essen, Belgium.
| | | | - Mathias Devreese
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
| |
Collapse
|
6
|
Catteuw A, Broekaert N, De Baere S, Lauwers M, Gasthuys E, Huybrechts B, Callebaut A, Ivanova L, Uhlig S, De Boevre M, De Saeger S, Gehring R, Devreese M, Croubels S. Insights into In Vivo Absolute Oral Bioavailability, Biotransformation, and Toxicokinetics of Zearalenone, α-Zearalenol, β-Zearalenol, Zearalenone-14-glucoside, and Zearalenone-14-sulfate in Pigs. J Agric Food Chem 2019; 67:3448-3458. [PMID: 30807145 DOI: 10.1021/acs.jafc.8b05838] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The aim of this study was to determine the toxicokinetic characteristics of ZEN and its modified forms, α-zearalenol (α-ZEL), β-zearalenol (β-ZEL), zearalenone-14-glucoside (ZEN14G), and zearalenone-14-sulfate (ZEN14S), including presystemic and systemic hydrolysis in pigs. Crossover pig trials were performed by means of intravenous and oral administration of ZEN and its modified forms. Systemic plasma concentrations of the administered toxins and their metabolites were quantified and further processed via tailor-made compartmental toxicokinetic models. Furthermore, portal plasma was analyzed to unravel the site of hydrolysis, and urine samples were analyzed to determine urinary excretion. Results demonstrate complete presystemic hydrolysis of ZEN14G and ZEN14S to ZEN and high oral bioavailability for all administered compounds, with further extensive first-pass glucuronidation. Conclusively, the modified-ZEN forms α-ZEL, β-ZEL, ZEN14G, and ZEN14S contribute to overall ZEN systemic toxicity in pigs and should be taken into account for risk assessment.
Collapse
Affiliation(s)
- Amelie Catteuw
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine , Ghent University , Salisburylaan 133 , 9820 Merelbeke , Belgium
| | - Nathan Broekaert
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine , Ghent University , Salisburylaan 133 , 9820 Merelbeke , Belgium
| | - Siegrid De Baere
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine , Ghent University , Salisburylaan 133 , 9820 Merelbeke , Belgium
| | - Marianne Lauwers
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine , Ghent University , Salisburylaan 133 , 9820 Merelbeke , Belgium
| | - Elke Gasthuys
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine , Ghent University , Salisburylaan 133 , 9820 Merelbeke , Belgium
| | - Bart Huybrechts
- Sciensano , Juliette Wytsmanstraat 14 , 1050 Elsene , Belgium
| | | | - Lada Ivanova
- Chemistry Section , Norwegian Veterinary Institute , Ullevålsveien 68 , 0454 Oslo , Norway
| | - Silvio Uhlig
- Chemistry Section , Norwegian Veterinary Institute , Ullevålsveien 68 , 0454 Oslo , Norway
| | - Marthe De Boevre
- Department of Bioanalysis, Faculty of Pharmaceutical Sciences , Ghent University , Ottergemsesteenweg 460 , 9000 Ghent , Belgium
| | - Sarah De Saeger
- Department of Bioanalysis, Faculty of Pharmaceutical Sciences , Ghent University , Ottergemsesteenweg 460 , 9000 Ghent , Belgium
| | - Ronette Gehring
- Institute of Computational Comparative Medicine, College of Veterinary Medicine , Kansas State University , 1700 Denison Ave , Manhattan , Kansas 66506 , United States
- Institute of Risk Assessment Sciences, Division of Toxicology/Pharmacology , Utrecht University , Yalelaan 1 , 3584 CL Utrecht , The Netherlands
| | - Mathias Devreese
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine , Ghent University , Salisburylaan 133 , 9820 Merelbeke , Belgium
- Institute of Computational Comparative Medicine, College of Veterinary Medicine , Kansas State University , 1700 Denison Ave , Manhattan , Kansas 66506 , United States
| | - Siska Croubels
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine , Ghent University , Salisburylaan 133 , 9820 Merelbeke , Belgium
| |
Collapse
|
7
|
Lauwers M, De Baere S, Letor B, Rychlik M, Croubels S, Devreese M. Multi LC-MS/MS and LC-HRMS Methods for Determination of 24 Mycotoxins including Major Phase I and II Biomarker Metabolites in Biological Matrices from Pigs and Broiler Chickens. Toxins (Basel) 2019; 11:toxins11030171. [PMID: 30893895 PMCID: PMC6468661 DOI: 10.3390/toxins11030171] [Citation(s) in RCA: 44] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2019] [Revised: 03/01/2019] [Accepted: 03/12/2019] [Indexed: 12/26/2022] Open
Abstract
A reliable and practical multi-method was developed for the quantification of mycotoxins in plasma, urine, and feces of pigs, and plasma and excreta of broiler chickens using liquid chromatography–tandem mass spectrometry. The targeted mycotoxins belong to the regulated groups, i.e., aflatoxins, ochratoxin A and Fusarium mycotoxins, and to two groups of emerging mycotoxins, i.e., Alternaria mycotoxins and enniatins. In addition, the developed method was transferred to a LC-high resolution mass spectrometry instrument to qualitatively determine phase I and II metabolites, for which analytical standards are not always commercially available. Sample preparation of plasma was simple and generic and was accomplished by precipitation of proteins alone (pig) or in combination with removal of phospholipids (chicken). A more intensive sample clean-up of the other matrices was needed and consisted of a pH-dependent liquid–liquid extraction (LLE) using ethyl acetate (pig urine), methanol/ethyl acetate/formic acid (75/24/1, v/v/v) (pig feces) or acetonitrile (chicken excreta). For the extraction of pig feces, additionally a combination of LLE using acetone and filtration of the supernatant on a HybridSPE-phospholipid cartridge was applied. The LC-MS/MS method was in-house validated according to guidelines defined by the European and international community. Finally, the multi-methods were successfully applied in a specific toxicokinetic study and a screening study to monitor the exposure of individual animals.
Collapse
Affiliation(s)
- Marianne Lauwers
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
- Innovad, Postbaan 69, 2910 Essen, Belgium.
| | - Siegrid De Baere
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
| | - Ben Letor
- Innovad, Postbaan 69, 2910 Essen, Belgium.
| | - Michael Rychlik
- Chair of Analytical Food Chemistry, Technische Universität München, Maximus-von-Imhof-Forum 2, 85354 Freising, Germany.
| | - Siska Croubels
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
| | - Mathias Devreese
- Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
| |
Collapse
|
8
|
Yousefi A, Lauwers M, Nemes R, van Holten T, Babae N, Roest M, Storm G, Schiffelers R, Mastrobattista E. Hemocompatibility Assessment of two siRNA Nanocarrier Formulations. Pharm Res 2014; 31:3127-35. [DOI: 10.1007/s11095-014-1405-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2014] [Accepted: 04/28/2014] [Indexed: 12/21/2022]
|
9
|
Ombelet W, Lauwers M, Verswijvel G, Grieten M, Hinoul P, Mestdagh G. Endometrial ossification and infertility: the diagnostic value of different imaging techniques. ACTA ACUST UNITED AC 2004; 28:893-6. [PMID: 14753614 DOI: 10.1007/s00261-003-0046-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
We present a case of longstanding secondary subfertility caused by endometrial ossification. Of all diagnostic techniques performed, magnetic resonance imaging and hysterosalpingography did not detect the abnormality. Transvaginal ultrasound and computed tomography clearly showed the endometrial pathology. After successful operative hysteroscopy with removal of the osseous tissue, the patient became pregnant spontaneously within 2 months.
Collapse
Affiliation(s)
- W Ombelet
- Department of Obstetrics and Gynecology, Ziekenhuizen Oost-Limburg, Schiepse Bos 6, 3600 Genk, Belgium
| | | | | | | | | | | |
Collapse
|
10
|
Lauwers M, Camu F, Breivik H, Hagelberg A, Rosen M, Sneyd R, Horn A, Noronha D, Shaikh S. The safety and effectiveness of remifentanil as an adjunct sedative for regional anesthesia. Anesth Analg 1999; 88:134-40. [PMID: 9895080 DOI: 10.1097/00000539-199901000-00025] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
UNLABELLED We assessed the sedative potential of continuous infusions of remifentanil with a validated composite alertness scale in 160 patients (ASA physical status I or II) undergoing hip replacement surgery with spinal block (n = 61) or hand surgery using brachial plexus block (n = 93). They were randomized to receive one of the following initial dose regimens in double-blinded fashion: placebo or 0.04, 0.07, or 0.1 microg x kg(-1) x min(-1) remifentanil subsequently titrated to effect. Additional midazolam IV was allowed for adequate sedation as required. The combined analysis of both surgery groups revealed a dose-related increase in achievement of sedation level > or =2 within 15 min of the start of the study drug infusion; all remifentanil dose comparisons with placebo reached significance (P < 0.001). The remifentanil 50% effective dose for a composite sedation level > or =2 within 15 min of the start of drug infusion was estimated as 0.043 microg x kg(-1) x min(-1) (95% confidence interval 0.01, 0.059). The requirement for midazolam decreased with increasing remifentanil dose compared with placebo (P < 0.001). The median time to return to alertness after the end of infusion was 10-12 min in the remifentanil groups and 5 min in the placebo group. Significant incidences of nausea, pruritus, sweating, and respiratory depression were reported during remifentanil infusions compared with placebo. The data suggest that remifentanil may be useful for supplementation of regional anesthesia, provided that ventilation is carefully monitored. IMPLICATIONS In this dose-finding, placebo-controlled study, remifentanil infusions were used to provide sedation during spinal and brachial plexus regional anesthesia. The 50% effective dose for achievement of sedation was 0.043 microg x kg(-1) x min(-1). Return to alertness occurred after 10-12 min (median time). Remifentanil infusions can be used to supplement regional anesthesia, but this requires careful monitoring of ventilation.
Collapse
Affiliation(s)
- M Lauwers
- Department of Anesthesiology, Flemish Free University of Brussels Medical Center, Belgium
| | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Camu F, Lauwers M, Vanlersberghe C. Basic principles of pharmacokinetics and pharmacodynamics for the anesthesiologist. Acta Anaesthesiol Belg 1998; 49:55-64. [PMID: 9675374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- F Camu
- Department of Anesthesiology, Flemish Free University of Brussels Medical Center, Belgium
| | | | | |
Collapse
|
12
|
Boonkerd S, Lauwers M, Detaevernier M, Michotte Y. Separation and simultaneous determination of the components in an analgesic tablet formulation by micellar electrokinetic chromatography. J Chromatogr A 1995. [DOI: 10.1016/0021-9673(94)01183-f] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
13
|
Verborgh C, Van Gool R, Lauwers M, Dupont A, Camu F. Haemodynamic effects of draflazine in cabg patients. J Cardiothorac Vasc Anesth 1994. [DOI: 10.1016/1053-0770(94)90315-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
14
|
Lauwers M. Diphosphorus tetraiodide (P4I4) a valuable reagent for regioselective synthesis of iodoalkanes from alcohols. Tetrahedron Lett 1979. [DOI: 10.1016/s0040-4039(01)94665-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
15
|
Bazex A, Oksman F, Bazex J, Lauwers M. [Herpes gestationis. Immunofluorescent and electron microscopy studies]. Ann Dermatol Venereol 1977; 104:482-4. [PMID: 335950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
16
|
Bazex A, Oksman F, Bazex J, Lauwers M. [Herpes gestationis. Immunofluorescence and electron microscopy studies]. Ann Dermatol Venereol 1977; 104:482-4. [PMID: 332037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|